Skyline Diagnostics Preps Leukemia Test for US Launch; Gains CE-IVD Mark
March 15, 2011
Skyline Diagnostics Preps Leukemia Test for US Launch; Gains CE-IVD Mark
Skyline has received $1.5 million from the Dutch government to support a clinical study of AMLprofiler that will generate data it can use when it seeks US Food and Drug Administration clearance for the test next year.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.